ArticleTranslational cancer research2024

Targeting the EZH2-SLFN11 pathway-a lesson in developing molecularly-informed treatments for recurrent small cell lung cancer.

Fangdi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.